190 related articles for article (PubMed ID: 8981668)
1. Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.
Koivisto P; Visakorpi T; Kallioniemi OP
Scand J Clin Lab Invest Suppl; 1996; 226():57-63. PubMed ID: 8981668
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi OP
Cancer Res; 1997 Jan; 57(2):314-9. PubMed ID: 9000575
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.
Palmberg C; Koivisto P; Hyytinen E; Isola J; Visakorpi T; Kallioniemi OP; Tammela T
Eur Urol; 1997; 31(2):216-9. PubMed ID: 9076469
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer.
Edwards J; Krishna NS; Mukherjee R; Watters AD; Underwood MA; Bartlett JM
BJU Int; 2001 Oct; 88(6):633-7. PubMed ID: 11678763
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
Palmberg C; Koivisto P; Kakkola L; Tammela TL; Kallioniemi OP; Visakorpi T
J Urol; 2000 Dec; 164(6):1992-5. PubMed ID: 11061898
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in understanding hormonal therapy resistant prostate cancer.
Donkena KV; Yuan H; Young CY
Curr Cancer Drug Targets; 2010 Jun; 10(4):402-10. PubMed ID: 20464780
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway.
Mellado B; Codony J; Ribal MJ; Visa L; Gascón P
Clin Transl Oncol; 2009 Jan; 11(1):5-10. PubMed ID: 19155198
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations during progression of prostate cancer to androgen independence.
Saraon P; Jarvi K; Diamandis EP
Clin Chem; 2011 Oct; 57(10):1366-75. PubMed ID: 21956922
[TBL] [Abstract][Full Text] [Related]
9. Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy.
Sharifi N; Kawasaki BT; Hurt EM; Farrar WL
Cancer Biol Ther; 2006 Aug; 5(8):901-6. PubMed ID: 16855379
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer.
Nguyen MM; Wang Z
Minerva Urol Nefrol; 2008 Mar; 60(1):15-29. PubMed ID: 18427432
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.
Haapala K; Kuukasjärvi T; Hyytinen E; Rantala I; Helin HJ; Koivisto PA
Hum Pathol; 2007 Mar; 38(3):474-8. PubMed ID: 17217995
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanisms involved in hormone resistance of prostate cancer].
Cabrespine A; Guy L; Chollet P; Debiton E; Bay JO
Bull Cancer; 2004 Oct; 91(10):747-57. PubMed ID: 15556875
[TBL] [Abstract][Full Text] [Related]
13. Alterations of androgen receptor in prostate cancer.
Linja MJ; Visakorpi T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):255-64. PubMed ID: 15663988
[TBL] [Abstract][Full Text] [Related]
14. The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer.
Kageyama Y; Hyochi N; Kihara K; Sugiyama H
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):203-11. PubMed ID: 18221063
[TBL] [Abstract][Full Text] [Related]
15. The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic test.
Ross JS
Adv Anat Pathol; 2007 Sep; 14(5):353-7. PubMed ID: 17717436
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms leading to the development of hormone-resistant prostate cancer.
Kasper S; Cookson MS
Urol Clin North Am; 2006 May; 33(2):201-10, vii. PubMed ID: 16631458
[TBL] [Abstract][Full Text] [Related]
17. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
18. Role of androgen receptor splice variants, their clinical relevance and treatment options.
Wach S; Taubert H; Cronauer M
World J Urol; 2020 Mar; 38(3):647-656. PubMed ID: 30659302
[TBL] [Abstract][Full Text] [Related]
19. In vivo amplification of the androgen receptor gene and progression of human prostate cancer.
Visakorpi T; Hyytinen E; Koivisto P; Tanner M; Keinänen R; Palmberg C; Palotie A; Tammela T; Isola J; Kallioniemi OP
Nat Genet; 1995 Apr; 9(4):401-6. PubMed ID: 7795646
[TBL] [Abstract][Full Text] [Related]
20. Androgen axis in prostate cancer.
Culig Z; Bartsch G
J Cell Biochem; 2006 Oct; 99(2):373-81. PubMed ID: 16598769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
